Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Genesis Acquires 100% Of Biostore NZ Ltd

Genesis Acquires 100% Of Biostore NZ Ltd And First Commercial Licensing Agreement For Biostore™ Is Signed

Auckland, 15 August 2001 - New Zealand biotechnology company, Genesis Research and Development Corporation (NZSE/ASX: GEN), today announced that it had acquired the remaining 23.7% interest in its subsidiary, BioStore NZ Limited, at independent valuation.

“The existing capital structure of BioStore could not adequately support our commercialisation plans,” says Genesis Chief Executive, Dr Jim Watson. “By acquiring the minority interest, Genesis can now provide the support required for the development and commercialisation of BioStore™ products.”

Genesis will issue approximately 230,000 shares and make a small cash payment to the vendors.

BioStore™ is a patented preservation technology which physically induces dormancy in cellular products. This allows cells to be stored at 4ºC or frozen and later thawed without deterioration. Alternatively, BioStore™ treated cells can be freeze-dried, stored without refrigeration, and later reconstituted. This provides new storage and distribution opportunities and can reduce the costs of traditional storage technologies.

BioStore has also licensed its technology to Australian veterinary pharmaceuticals and animal health products manufacturer, Jurox Pty Ltd.

The agreement, which represents the first commercial application of BioStore™, enables Jurox to freeze-dry nucleated cellular products stored in a BioStore™ solution, and later revive them in a novel veterinary application.

As a result of this agreement BioStore will realise royalty income based on Jurox’s commercial success. Meanwhile Jurox is exploring further potential veterinary applications for BioStore™.

“BioStore’s unique preservation technology makes possible a whole new class of product formulations and treatment delivery systems for veterinary applications,” says Jurox CEO, John O’Brien. “We believe we have the potential to open up a range of veterinary opportunities for BioStore.”

Investing in BioStore
As it moves to commercialise the technology Genesis has considerably strengthened its BioStore team. It has contracted Dr Earl Stevens to manage the development of commercial applications. With a PhD in Biochemistry, a background in general management, mergers and commercial development, Dr Stevens is tasked with identifying, prioritising and speeding up the development of BioStore opportunities with strong commercial potential.

“The future commercialisation of BioStore’s patented technologies will be via agreements such as this,” says Dr Stevens. “Our primary focus for the near term will be on blood product applications, including platelet and red blood cell storage, where our ability to store platelets for 21 days at 4° C represents a significant advantage over other storage technologies.”

Genesis has also appointed a Chief Scientist for BioStore, Dr Anthony Matthews. A New Zealander and graduate of the University of Auckland, Dr Matthews has worked extensively in North America, at Rice University in Texas and Baxter Haemoglobin in Colorado. He is a biochemist with a background in physical chemistry, has worked with a wide range of tissues and holds a number of recombinant haemoglobin and protein purification related patents. Genesis has also appointed Dr Helen Cao to the BioStore team. She holds a Bachelor’s degree in medicine and a Masters in microbiology and immunology from Nanjing Medical University, and has recently completed a Masters in health sciences and a PhD at Auckland University.


About Genesis
Founded in 1994, Genesis is a New Zealand-based biotechnology company committed to the building of a strong genomic platform for the development of innovative products in human health and agriculture. Genesis partners with industry leaders to develop products that have global market potential through the mining of its extensive microbe, plant and mammalian EST databases. Genesis has three programs in human clinical development, with additional programs in pre-clinical development and in plant biotechnology. Genesis now owns 100 percent of the shares in BioStore NZ Ltd, which in turn owns all the patents to BioStore™ preservation solutions. For more information, please visit

# # #

© Scoop Media

Business Headlines | Sci-Tech Headlines


I Sing The Highway Electric: Charge Net NZ To Connect New Zealand

BMW is turning Middle Earth electric after today announcing a substantial contribution to the charging network Charge Net NZ. This landmark partnership will enable Kiwis to drive their electric vehicles (EVs) right across New Zealand through the installation of a fast charging highway stretching from Kaitaia to Invercargill. More>>


Watch This Space: Mahia Rocket Lab Launch Site Officially Opened

Economic Development Minster Steven Joyce today opened New Zealand’s first orbital launch site, Rocket Lab Launch Complex 1, on the Mahia Peninsula on the North Island’s east coast. More>>


Marketing Rocks!
Ig Nobel Award Winners Assess The Personality Of Rocks

A Massey University marketing lecturer has received the 2016 Ig Nobel Prize for economics for a research project that asked university students to describe the “brand personalities” of three rocks. More>>


Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>


Half A Billion Accounts, Including Xtra: Yahoo Confirms Huge Data Breach

The account information may have included names, email addresses, telephone numbers, dates of birth, hashed passwords (the vast majority with bcrypt) and, in some cases, encrypted or unencrypted security questions and answers. More>>


Rural Branches: Westpac To Close 19 Branches, ANZ Looks At 7

Westpac confirms it will close nineteen branches across the country; ANZ closes its Ngaruawahia branch and is consulting on plans to close six more branches; The bank workers union says many of its members are nervous about their futures and asking ... More>>

Interest Rates: RBNZ's Wheeler Keeps OCR At 2%

Reserve Bank governor Graeme Wheeler kept the official cash rate at 2 percent and said more easing will be needed to get inflation back within the target band. More>>


Get More From Scoop

Search Scoop  
Powered by Vodafone
NZ independent news